Effect of diabetes status and hyperglycemia on global DNA methylation and hydroxymethylation

Endocrine Connections

Volumn 6, Issue 8, 2017, Pages 708-725

  Pinzón Cortés, Jairo Arturo ^a   Perna Chaux, Angelina ^a   Rojas Villamizar, Nicolás Steven ^a   Díaz Basabe, Angélica ^a   Polanía Villanueva, Diana Carolina ^a   Jácome, María Fernanda ^a   Mendivil, Carlos Olimpo ^a,b   Groot, Helena ^a   López Segura, Valeriano ^a  

^a UNIVERSIDAD DE LOS ANDES   (Colombia)

^b HOSPITAL UNIVERSITARIO FUNDACIÓN SANTA FE DE BOGOTÁ   (Colombia)

Author keywords

Diabetes; DNA hydroxymethylation; DNA methylation; Oxidation

Indexed keywords

DNA CYTOSINE 5 METHYLTRANSFERASE 1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN A1C; INTERLEUKIN 6; OXOGUANINE DNA GLYCOSYLASE; PEPTIDES AND PROTEINS; TET METHYLCYTOSINE DIOXYGENASE 1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ALCOHOL CONSUMPTION; ALKYLATION; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DNA METHYLATION; DNA PURIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIGENETICS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYDROXYMETHYLATION; HYPERGLYCEMIA; LIFESTYLE; MALE; MICROARRAY ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTON TRANSPORT; REPRESSOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY; TOBACCO CONSUMPTION;

EID: 85034612746     PISSN: None     EISSN: 20493614     Source Type: Journal    
DOI: 10.1530/EC-17-0199     Document Type: Article

References (44)

1. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005 54 1615-1625. (doi:10.2337/diabetes.54.6.1615)
2. Shaw JE, Sicree RA & Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice 2010 87 4-14. (doi:10.1016/j.diabres.2009.10.007)
3. Inadera H. Developmental origins of obesity and type 2 diabetes: molecular aspects and role of chemicals. Environmental Health and Preventive Medicine 2013 18 185-197. (doi:10.1007/s12199-013-0328-8)
4. Salbaum JM & Kappen C. Responses of the embryonic epigenome to maternal diabetes. Birth Defects Research Part A: Clinical and Molecular Teratology 2012 94 770-781. (doi:10.1002/bdra.23035)
5. Desiderio A, Spinelli R, Ciccarelli M, Nigro C, Miele C, Beguinot F & Raciti GA. Epigenetics: spotlight on type 2 diabetes and obesity. Journal of Endocrinological Investigation 2016 39 1095-103. (doi:10.1007/s40618-016-0473-1)
6. Lawlor N, Khetan S, Ucar D & Stitzel ML. Genomics of islet (Dys) function and Type 2 diabetes. Trends in Genetics 2017 33 244-255. (doi:10.1016/j.tig.2017.01.010)
7. Ling C, Del Guerra S, Lupi R, Rönn T, Granhall C, Luthman H, Masiello P, Marchetti P, Groop L & Del Prato S. Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia 2008 51 615-622. (doi:10.1007/s00125-007-0916-5)
8. Park JH, Stoffers DA, Nicholls RD & Simmons RA. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. Journal of Clinical Investigation 2008 118 2316-2324. (doi:10.1172/JCI33655)
9. Sommese L, Zullo A, Mancini FP, Fabbricini R, Soricelli A & Napoli C. Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus. Epigenetics 2017 12 401-415. (doi:10.1080/15592294.2016.1278097)
10. Fuschi P, Maimone B, Gaetano C & Martelli F. Noncoding RNAs in the vascular system response to oxidative stress. Antioxidants and Redox Signaling 2017 [in press]. (doi:10.1089/ars.2017.7229)
11. Intine RV & Sarras MP. Metabolic memory and chronic diabetes complications: potential role for epigenetic mechanisms. Current Diabetes Reports 2012 12 551-559. (doi:10.1007/s11892-012-0302-7)
12. El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, Cooper ME & Brownlee M. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. Journal of Experimental Medicine 2008 205 2409-2417. (doi:10.1084/jem.20081188)
13. Cooper ME & El-Osta A. Epigenetics: mechanisms and implications for diabetic complications. Circulation Research 2010 107 1403-1413. (doi:10.1161/CIRCRESAHA.110.223552)
14. Rakyan VK, Beyan H, Down TA, Hawa MI, Maslau S, Aden D, Daunay A, Busato F, Mein CA, Manfras B, et al. Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis. PLOS Genetics 2011 7 e1002300. (doi:10.1371/journal.pgen.1002300)
15. Volkmar M, Dedeurwaerder S, Cunha DA, Ndlovu MN, Defrance M, Deplus R, Calonne E, Volkmar U, Igoillo-Esteve M, Naamane N, et al. DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients. EMBO Journal 2012 31 1405-1426. (doi:10.1038/emboj.2011.503)
16. Williams KT, Garrow TA & Schalinske KL. Type I diabetes leads to tissue-specific DNA hypomethylation in male rats. Journal of Nutrition 2008 138 2064-2069. (doi:10.3945/jn.108.094144)
17. Williams KT & Schalinske KL. Tissue-specific alterations of methyl group metabolism with DNA hypermethylation in the Zucker (type 2) diabetic fatty rat. Diabetes/Metabolism Research and Reviews 2012 28 123-131. (doi:10.1002/dmrr.1281)
18. Caudill MA, Wang JC, Melnyk S & Pogribny IP. Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine β-synthase heterozygous mice. Journal of Nutrition 2001 131 2811-2818.
19. Chen NC, Yang F, Capecci LM, Gu Z, Schafer AI, Durante W, Yang X-F & Wang H. Regulation of homocysteine metabolism and methylation in human and mouse tissues. FASEB Journal 2010 24 2804-2817. (doi:10.1096/fj.09-143651)
20. Patti M-E & Corvera S. The role of mitochondria in the pathogenesis of type 2 diabetes. Endocrine Reviews 2010 31 364-395. (doi:10.1210/er.2009-0027)
21. Ulrey CL, Liu L, Andrews LG & Tollefsbol TO. The impact of metabolism on DNA methylation. Human Molecular Genetics 2005 14 R139-R147. (doi:10.1093/hmg/ddi100)
22. Wallace DC & Fan W. Energetics, epigenetics, mitochondrial genetics. Mitochondrion 2010 10 12-31. (doi:10.1016/j.mito.2009.09.006)
23. Chavali V, Tyagi SC & Mishra PK. MicroRNA-133a regulates DNA methylation in diabetic cardiomyocytes. Biochemical and Biophysical Research Communications 2012 425 668-672. (doi:10.1016/j.bbrc.2012.07.105)
24. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009 324 930-935. (doi:10.1126/science.1170116)
25. Koh KP, Yabuuchi A, Rao S, Huang Y, Cunniff K, Nardone J, Laiho A, Tahiliani M, Sommer CA, Mostoslavsky G, et al. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell 2011 8 200-213. (doi:10.1016/j.stem.2011.01.008)
26. Klug M, Schmidhofer S, Gebhard C, Andreesen R & Rehli M. 5-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytes. Genome Biology 2013 14 R46. (doi:10.1186/gb-2013-14-5-r46)
27. la Rica de L, Rodríguez-Ubreva J, García M, Islam AB, Urquiza JM, Hernando H, Christensen J, Helin K, Gómez-Vaquero C & Ballestar E. PU.1 target genes undergo Tet2-coupled demethylation and DNMT3b-mediated methylation in monocyte-to-osteoclast differentiation. Genome Biology 2013 14 R99. (doi:10.1186/gb-2013-14-9-r99)
28. Valinluck V & Sowers LC. Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Research 2007 67 946-950. (doi:10.1158/0008-5472.CAN-06-3123)
29. Branco MR, Ficz G & Reik W. Uncovering the role of 5-hydroxymethylcytosine in the epigenome. Nature Reviews Genetics 2012 13 7-13. (doi:10.1038/nrg3080)
30. Pabinger S, Rödiger S, Kriegner A, Vierlinger K & Weinhäusel A. A survey of tools for the analysis of quantitative PCR (qPCR) data. Biomolecular Detection and Quantification 2014 1 23-33. (doi:10.1016/j.bdq.2014.08.002)
31. Edgar R, Domrachev M & Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Research 2002 30 207-210. (doi:10.1093/nar/30.1.207)
32. Burchett WW, Ellis AR, Harrar SW & Bathke AC. Nonparametric inference for multivariate data: the RPackage npmv. Journal of Statistical Software 2017 76 1-18. (doi:10.18637/jss.v076.i04)
33. Burnham KP, Anderson DR & Huyvaert KP. AIC model selection and multimodel inference in behavioral ecology: some background, observations, and comparisons. Behavioral Ecology and Sociobiology 2010 65 23-35. (doi:10.1007/s00265-010-1029-6)
34. Heyn H, Moran S & Esteller M. Aberrant DNA methylation profiles in the premature aging disorders Hutchinson-Gilford Progeria and Werner syndrome. Epigenetics 2013 8 28-33. (doi:10.4161/epi.23366)
35. Choi S-W & Friso S. Nutrients and Epigenetics. Boca Raton, FL, USA: CRC Press, 2009.
36. Olsen AS, Sarras MP & Intine RV. Limb regeneration is impaired in an adult zebrafish model of diabetes mellitus. Wound Repair and Regeneration 2010 18 532-542. (doi:10.1111/j.1524-475X.2010.00613.x)
37. Chia N, Wang L, Lu X, Senut M-C, Brenner C & Ruden DM. Hypothesis: environmental regulation of 5-hydroxymethylcytosine by oxidative stress. Epigenetics 2011 6 853-856. (doi:10.4161/epi.6.7.16461)
38. Olsen AS, Sarras MP, Leontovich A & Intine RV. Heritable transmission of diabetic metabolic memory in zebrafish correlates with DNA hypomethylation and aberrant gene expression. Diabetes 2012 61 485-491. (doi:10.2337/db11-0588)
39. Bottiglieri T, Laundy M, Crellin R, Toone BK, Carney MW & Reynolds EH. Homocysteine, folate, methylation, and monoamine metabolism in depression. Journal of Neurology, Neurosurgery, and Psychiatry 2000 69 228-232. (doi:10.1136/jnnp.69.2.228)
40. Nieratschker V, Batra A & Fallgatter AJ. Genetics and epigenetics of alcohol dependence. Journal of Molecular Psychiatry 2013 1 11. (doi:10.1186/2049-9256-1-11)
41. Bönsch D, Lenz B, Fiszer R, Frieling H, Kornhuber J & Bleich S. Lowered DNA methyltransferase (DNMT-3b) mRNA expression is associated with genomic DNA hypermethylation in patients with chronic alcoholism. Journal of Neural Transmission 2006 113 1299-1304. (doi:10.1007/s00702-005-0413-2)
42. Lee KWK & Pausova Z. Cigarette smoking and DNA methylation. Frontiers in Genetics 2013 4 132. (doi:10.3389/fgene.2013.00132)
43. Arroyo-Jousse V, Garcia-Diaz DF, Codner E & Pérez-Bravo F. Epigenetics in type 1 diabetes: TNFa gene promoter methylation status in Chilean patients with type 1 diabetes mellitus. British Journal of Nutrition 2016 116 1861-1868. (doi:10.1017/S0007114516003846)
44. Zhou X, Zhuang Z, Wang W, He L, Wu H, Cao Y, Pan F, Zhao J, Hu Z, Sekhar C, et al. OGG1 is essential in oxidative stress induced DNA demethylation. Cell Signaling 2016 28 1163-1171. (doi:10.1016/j.cellsig.2016.05.021)